H-1B sponsorship profile: Novitium Pharma LLC. Across U.S. Department of Labor LCA disclosures, Novitium Pharma LLC filed 187 Labor Condition Applications covering 187 H-1B worker positions between fiscal year 2023 and fiscal year 2026. The employer’s DOL certification rate sits at 99.5% (186 certified of 187 filed), a useful proxy for how cleanly their prevailing-wage attestations pass the Labor Department’s preliminary review before USCIS adjudication.

Compensation spread. Offered wages on Novitium Pharma LLC’s H-1B petitions range from $60,000 at the low end to $210,000 at the high end, with a petition-weighted average of $82,915. That range reflects the mix of occupations the company sponsors, led by Quality Control Analyst (36 petitions at $67,584 avg), followed by Chemist and Sr. Quality Control Analyst. H-1B salaries reported on LCAs must meet or exceed the DOL prevailing wage for the role and worksite, so the spread also tracks wage-level geography and seniority.

Geographic footprint. Novitium Pharma LLC is headquartered in EAST WINDSOR, NJ under NAICS code 325412, and places H-1B workers across 2 states, most heavily in NJ, NC. Combined, these signals give a granular view of how one employer uses the H-1B program, volume, approval cleanliness, wage posture, and where the jobs actually sit on the map.